COMMUNIQUÉS West-GlobeNewswire

AIM ImmunoTech Announces Pricing of $1.26 Million Registered Direct Offering
30/09/2024
OCALA, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional [...]
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules
30/09/2024
SALT LAKE CITY, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly-owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
30/09/2024
CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
Digicann Ventures Signs Definitive Agreement for Proposed RTO Transaction with 3Win Corp.
28/09/2024
/ Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, Sept. 28, 2024 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: [...]
Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
28/09/2024
Updated Phase 1 data presented at ESH-iCMLf 26 th Annual John Goldman Conference Reported cumulative MMR rate of 44% (8/18) by 24 weeks, with stable or deepening responses between weeks 12 and 24, which continues to [...]
Montréal accueille le 4e Symposium international sur l’arthrogrypose congénitale multiple (ACM)
28/09/2024
MONTRÉAL, 28 sept. 2024 (GLOBE NEWSWIRE) -- Du 28 septembre au 1er octobre prochains, l’Hôpital Shriners pour enfants Canada sera l’hôte du 4ème symposium international sur l'arthrogrypose . Organisé en collaboration [...]
Montreal hosts the 4th International Symposium on Arthrogryposis Multiplex Congenita (AMC)
28/09/2024
MONTREAL, Sept. 28, 2024 (GLOBE NEWSWIRE) -- From September 28 to October 1, the Shriners Hospitals for Children - Canada will host the 4 th International Symposium on Arthrogryposis . Organized in collaboration with [...]
SOGC Calls for Vigilance and Continued Advocacy on International Safe Abortion Day
28/09/2024
OTTAWA, Ontario, Sept. 28, 2024 (GLOBE NEWSWIRE) -- As the world observes International Safe Abortion Day, the Society of Obstetricians and Gynaecologists of Canada (SOGC) is reaffirming its unwavering commitment to [...]
La SOGC lance un appel à la vigilance et à la poursuite des représentations pour protéger les droits des femmes à l'occasion de la Journée internationale de l'avortement sécuritaire
28/09/2024
OTTAWA, Ontario, 28 sept. 2024 (GLOBE NEWSWIRE) -- Alors que le monde entier observe la Journée internationale de l'avortement sécuritaire, la Société des obstétriciens et gynécologues du Canada (SOGC) réaffirme son [...]
Natural Alternatives International, Inc. Announces Fiscal 2024 Q4 and YTD Results
28/09/2024
CARLSBAD, Calif., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today [...]
BridgeBio Shares Recurrent Event Analysis of ATTRibute-CM, Demonstrating a 42% Reduction by Acoramidis on the Composite Endpoint of All-Cause Mortality and Recurrent Cardiovascular-related Hospitalization Events
28/09/2024
- Acoramidis treatment led to a highly significant reduction in all-cause mortality (ACM) and recurrent cardiovascular-related hospitalizations (CVH) at Month 30 compared with placebo - Additionally, results from a [...]
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
27/09/2024
Company to Focus on 510(k) Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today [...]
CARVYKTI® ▼ (ciltacabtagene autoleucel; cilta-cel) is the first cell therapy to significantly extend overall survival versus standard therapies for patients with multiple myeloma as early as second line
27/09/2024
45 percent reduction in risk of death achieved with cilta-cel versus standard therapies after three-year follow-up in landmark CARTITUDE-4 study 1 Data featured in a late-breaking oral presentation at the 2024 [...]
CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
27/09/2024
Landmark CARTITUDE-4 study results show CARVYKTI ® reduced the risk of death by 45 percent after three-year follow-up Late-breaking data featured in an oral presentation at the 21 st International Myeloma Society Annual [...]
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
27/09/2024
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update Additional clinical data on patients suffering from Obstructive Sleep Apnea (OSA) demonstrate a clinically [...]
Les Données de l'Étude Pivot DREAM Présentées lors de l'International Surgical Sleep Society 2024 Educational Update
27/09/2024
Les Données de l'Étude Pivot DREAM Présentées lors de l'International Surgical Sleep Society 2024 Educational Update Des données cliniques supplémentaires sur des patients souffrant d'apnée obstructive du sommeil (AOS) [...]
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27/09/2024
DELRAY BEACH, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. , dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS), today announced that on September 27, 2024, PetMeds granted two equity awards [...]
PacBio Grants Equity Incentive Award to New Employee
27/09/2024
MENLO PARK, Calif., Sept. 27, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s [...]
Neurona Therapeutics Announces Participation in Upcoming Investor Conferences in October
27/09/2024
SAN FRANCISCO, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that Cory R. [...]

Pages